Compare MPX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPX | SOPH |
|---|---|---|
| Founded | 1965 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.2M | 367.7M |
| IPO Year | N/A | 2021 |
| Metric | MPX | SOPH |
|---|---|---|
| Price | $8.17 | $4.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 43.7K | ★ 360.6K |
| Earning Date | 02-05-2026 | 03-03-2026 |
| Dividend Yield | ★ 6.93% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $244,419,000.00 | $73,297,000.00 |
| Revenue This Year | $3.97 | $18.48 |
| Revenue Next Year | $13.02 | $15.82 |
| P/E Ratio | $25.25 | ★ N/A |
| Revenue Growth | 3.32 | ★ 13.66 |
| 52 Week Low | $7.49 | $2.58 |
| 52 Week High | $10.08 | $5.70 |
| Indicator | MPX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 34.26 | 48.11 |
| Support Level | $9.23 | $4.60 |
| Resistance Level | $10.00 | $5.62 |
| Average True Range (ATR) | 0.40 | 0.32 |
| MACD | -0.21 | -0.07 |
| Stochastic Oscillator | 5.05 | 32.73 |
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.